252 related articles for article (PubMed ID: 20383599)
1. Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations.
Nadel MR; Berkowitz Z; Klabunde CN; Smith RA; Coughlin SS; White MC
J Gen Intern Med; 2010 Aug; 25(8):833-9. PubMed ID: 20383599
[TBL] [Abstract][Full Text] [Related]
2. A national survey of primary care physicians' methods for screening for fecal occult blood.
Nadel MR; Shapiro JA; Klabunde CN; Seeff LC; Uhler R; Smith RA; Ransohoff DF
Ann Intern Med; 2005 Jan; 142(2):86-94. PubMed ID: 15657156
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007.
Klabunde CN; Lanier D; Nadel MR; McLeod C; Yuan G; Vernon SW
Am J Prev Med; 2009 Jul; 37(1):8-16. PubMed ID: 19442479
[TBL] [Abstract][Full Text] [Related]
4. Variation in colorectal cancer testing between primary care physicians: a cross-sectional study in Switzerland.
Braun AL; Prati E; Martin Y; Dvořák C; Tal K; Biller-Andorno N; Bulliard JL; Cornuz J; Selby K; Auer R
Int J Public Health; 2019 Sep; 64(7):1075-1083. PubMed ID: 31201428
[TBL] [Abstract][Full Text] [Related]
5. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
[TBL] [Abstract][Full Text] [Related]
6. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
Miglioretti DL; Rutter CM; Bradford SC; Zauber AG; Kessler LG; Feuer EJ; Grossman DC
Med Care; 2008 Sep; 46(9 Suppl 1):S91-6. PubMed ID: 18725839
[TBL] [Abstract][Full Text] [Related]
7. Physicians' colorectal cancer screening discussion and recommendation patterns.
Zapka JM; Klabunde CN; Arora NK; Yuan G; Smith JL; Kobrin SC
Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):509-21. PubMed ID: 21239688
[TBL] [Abstract][Full Text] [Related]
8. A national survey of primary care physicians' colorectal cancer screening recommendations and practices.
Klabunde CN; Frame PS; Meadow A; Jones E; Nadel M; Vernon SW
Prev Med; 2003 Mar; 36(3):352-62. PubMed ID: 12634026
[TBL] [Abstract][Full Text] [Related]
9. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
[TBL] [Abstract][Full Text] [Related]
10. Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time.
Doubeni CA; Laiyemo AO; Young AC; Klabunde CN; Reed G; Field TS; Fletcher RH
Ann Fam Med; 2010; 8(4):299-307. PubMed ID: 20644184
[TBL] [Abstract][Full Text] [Related]
11. Predictors of colorectal cancer screening in diverse primary care practices.
Zimmerman RK; Nowalk MP; Tabbarah M; Grufferman S
BMC Health Serv Res; 2006 Sep; 6():116. PubMed ID: 16970813
[TBL] [Abstract][Full Text] [Related]
12. Physician barriers to population-based, fecal occult blood test-based colorectal cancer screening programs for average-risk patients.
McGregor S; Hilsden R; Yang H
Can J Gastroenterol; 2010 Jun; 24(6):359-64. PubMed ID: 20559577
[TBL] [Abstract][Full Text] [Related]
13. Family physicians' choices of and opinions on colorectal cancer screening modalities.
Zettler M; Mollon B; da Silva V; Howe B; Speechley M; Vinden C
Can Fam Physician; 2010 Sep; 56(9):e338-44. PubMed ID: 20841573
[TBL] [Abstract][Full Text] [Related]
14. Colorectal Cancer Screening in Ghana: Physicians' Practices and Perceived Barriers.
Lussiez A; Dualeh SHA; Dally CK; Opoku BK; Raghavendran K; Aitpillah F; Boateng E; Darkwah D; Gyasi-Sarpong KC; Kolars JC; Kwakye G
World J Surg; 2021 Feb; 45(2):390-403. PubMed ID: 33145608
[TBL] [Abstract][Full Text] [Related]
15. Nonrecommended breast and colorectal cancer screening for young women: a vignette-based survey.
Kadivar H; Goff BA; Phillips WR; Andrilla CH; Berg AO; Baldwin LM
Am J Prev Med; 2012 Sep; 43(3):231-9. PubMed ID: 22898115
[TBL] [Abstract][Full Text] [Related]
16. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
17. Use of fecal occult blood test in hospitalized patients: survey of physicians practicing in a large central Canadian health region and Canadian gastroenterologists.
Ip S; Sokoro AA; Buchel A; Wirtzfeld D; Konrad G; Fatoye T; Singh H
Can J Gastroenterol; 2013 Dec; 27(12):711-6. PubMed ID: 24340316
[TBL] [Abstract][Full Text] [Related]
18. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
Sharma VK; Corder FA; Fancher J; Howden CW
Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer screening practices in Alabama: a survey of primary care physicians.
Chapman K; Nicholls K; Sullivan MM; Crutchfield S; Shaw T; Perkins A; Reed E
J Cancer Educ; 2012 Dec; 27(4):687-94. PubMed ID: 22829231
[TBL] [Abstract][Full Text] [Related]
20. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
